Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nimesha Wijamuni has a total of 356 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A Global Core Patient-Reported Outcome Set for Menopause: Development and Validation of the cPRO-MARiE Framework Across Thirteen Countries (MARIE WP2a)

    by Gayathri Delanerolle, Ieera Madan-Aggarwal, Vindya Pathiraja, George Uchenna Eleje, Teck Hock Toh, Nirmala Rathnayake, Fred Tweneboah-Koduah, Nana Afful-Minta, Tharanga Mudalige, Jie Sun, et al.

    Background: Menopause affects more than one billion individuals worldwide, yet outcome measurement in research remains narrow, inconsistent, and largely focused on vasomotor and genitourinary symptoms. Existing frameworks do not adequately capture the broader functional and psychosocial impacts reported by patients. We aimed to develop and validate a global Core Patient-Reported Outcome Set for Menopause (cPRO-MARiE) using prospective mixed-methods data from thirteen countries. Methods: We analysed quantitative data from 5,228 participants and qualitative interviews from 302 individuals across thirteen countries spanning diverse socio-cultural and health-system contexts. Validated instruments assessed symptom severity, psychological wellbeing, cognitive function, sleep disturbance, pain and somatic symptoms, and functional outcomes. Qualitative data underwent reflexive thematic analysis guided by the Delanerolle–Phiri framework. A COMET-aligned process integrating quantitative severity patterns, qualitative thematic convergence, cross-country reproducibility, psychometric validation and equity considerations was applied to derive the core outcome set. Findings: Seven domains were consistently identified across all settings: sleep disturbance; psychological wellbeing; cognitive function; pain and somatic symptoms; vasomotor symptoms; genitourinary and sexual health; and social, relational and occupational functioning. These domains demonstrated conceptual stability, cross-country reproducibility and psychometric coherence and were strongly linked to functional impact. The resulting cPRO-MARiE specifies mandatory Tier 1 patient-reported outcomes within each domain, with Tier 2 outcomes retained for context-specific and equity-focused research. Interpretation: cPRO-MARiE is the first empirically derived, globally validated core outcome set for menopause. By capturing symptom domains and functional impacts prioritised by patients across diverse settings, it provides a robust and clinically meaningful framework for outcome measurement in research, routine care, and health-system evaluation.

  • Open Access

    Hidden in Plain Sight; Menopause as a Global Determinant of Burnout and Workforce Disruption: A Mixed-Methods Analysis from Thirteen Countries in MARIE WP2a

    by Gayathri Delanerolle, Ieera Madan-Aggarwal, Vindya Pathiraja, George Uchenna Eleje, Teck Hock Toh, Nirmala Rathnayake, Fred Tweneboah-Koduah, Nana Afful-Minta, Tharanga Mudalige, Jie Sun, et al.

    Background: Menopause is a universal life-course transition that coincides with midlife employment for a growing proportion of the global female workforce. Despite increasing recognition, robust cross-country evidence linking menopausal symptoms to burnout and workforce wellbeing remains limited, particularly outside high-income settings. Methods: This mixed-methods analysis draws on MARIE WP2a, a multi-country cross-sectional cohort of 5,133 participants aged 40–65 years across 13 countries (Brazil, Ghana, India, Sri Lanka, Malaysia, Nigeria, Nepal, Oman, Pakistan, Rwanda, Singapore, Tanzania, and the UK). Quantitative data assessed burnout using the Burnout Assessment Tool (BAT-12) and its subscales (exhaustion, mental distance, cognitive impairment, emotional impairment). Linear mixed-effects models examined associations with employment characteristics, health factors, and menopausal treatments. Qualitative interviews were synthesised with a topics guide using cross-country thematic analysis to contextualise workforce impacts. Results: Overall burnout burden was moderate (mean BAT-12 2.41, SD 0.84), with exhaustion and cognitive impairment most pronounced. Participants early in their current specialty (1–5 years) consistently demonstrated higher burnout and subscale scores than those with ≥21 years’ experience. Disability and long-term conditions were associated with significantly higher burnout across domains. Marked cross-country heterogeneity was observed, reflecting differences in labour structures and social protection. Qualitative findings revealed convergent mechanisms across countries: symptom-driven capacity loss, amplification by inflexible work structures, stigma and non-disclosure, reliance on informal support, policy absence, and financial precarity. Conclusions: Menopause substantially shapes workforce wellbeing across diverse economic and cultural contexts. Symptoms interact with job demands, stigma, and inequitable access to care to drive presenteeism, reduced productivity, and constrained occupational choice. Menopause-informed workplace policies, manager training, low-cost job adjustments, and equitable access to evidence-based care are urgently required to protect women’s health, workforce participation, and productivity in ageing economies.

  • Open Access

    Physical and mental health impact of perimenopause, menopause and post menopause in a diverse global population (MARIE Project- Global Chapter WP 2a): cross-sectional quantitative data from a mixed-methods study

    by Gayathri Delanerolle, Vindya Pathiraja, George Uchenna Eleje, Teck Hock Toh, Nirmala Rathnayake, Fred Tweneboah-Koduah, Nana Afful-Minta, Tharanga Mudalige, Jie Sun, Jeevan Dhanarisi, et al.

  • Open Access

    System Readiness for Digitally Enabled Clinical Trials in a LMIC Setting: A Cross-Sectional Pilot Study in Sri Lanka (DARWIN Project WP1)

    by Vindya Pathiraja, Jeevan Dhanarisi, Nimesha Wijayamuni, Thamudi Sundarapperuma, Nirmala Rathnayake, Peter Phiri, Gayathri Delanerolle

    Background: Decentralised clinical trials (DCTs) have emerged as a transformative approach to improve accessibility, inclusivity, and efficiency in clinical research. However, evidence on their feasibility and implementation readiness in low- and middle-income countries remains limited. This study aimed to assess stakeholder awareness, perceptions, and system readiness for DCT implementation in Sri Lanka. Methods: A cross-sectional survey was conducted among 87 stakeholders, including academics, healthcare professionals, researchers, and regulatory personnel. Data were collected using a structured questionnaire assessing awareness, attitudes, perceived benefits and barriers, and readiness for DCT implementation. Descriptive statistics summarised responses, while bivariate analyses (chi-square and Fisher’s exact tests) and multivariable logistic regression were used to identify factors associated with perceived preparedness. Findings: Awareness of DCTs was moderate (62.1%), and most participants recognised their potential to improve trial participation (88.5%). However, only 31.0% reported feeling adequately prepared to engage in DCTs. Institutional readiness was limited, with low availability of infrastructure (31.0%) and policies (16.1%). Regulatory familiarity (13.8%) and confidence in ethical guidance (10.3%) were also low. Key barriers included technological limitations (64.4%), data privacy concerns (58.6%), and patient safety issues (56.3%). Preparedness was significantly associated with prior training (p=0.019) and institutional infrastructure (OR 3.31, 95% CI 1.21–9.09), but not with level of understanding. These findings indicate that digital health system capacity, rather than stakeholder awareness, is the primary determinant of decentralised trial readiness.Interpretation: Stakeholders in Sri Lanka demonstrate strong conceptual support for DCTs but limited operational readiness. Implementation is constrained by gaps in digital health system capacity rather than attitudinal barriers. Context-specific investment in infrastructure, training, and regulatory frameworks is essential to ensure equitable and sustainable adoption of decentralised clinical trials.

  • Open Access

    Decentralised Clinical Trials in Low- and Middle-Income Settings: A Cross-Sectional Pilot Study of Feasibility and Readiness in Sri Lanka (DARWIN Project WP1)

    by Vindya Pathiraja, Jeevan Dhanarisi, Nimesha Wijamuni, Thamudi Sundarapperuma, Nirmala Rathnayake, Peter Phiri, Gayathri Delanerolle

    Background: Decentralised clinical trials (DCTs) have emerged as a transformative approach to improve accessibility, inclusivity, and efficiency in clinical research. However, evidence on their feasibility and implementation readiness in low- and middle-income countries remains limited. This study aimed to assess stakeholder awareness, perceptions, and system readiness for DCT implementation in Sri Lanka. Methods: A cross-sectional survey was conducted among 87 stakeholders, including academics, healthcare professionals, researchers, and regulatory personnel. Data were collected using a structured questionnaire assessing awareness, attitudes, perceived benefits and barriers, and readiness for DCT implementation. Descriptive statistics summarised responses, while bivariate analyses (chi-square and Fisher’s exact tests) and multivariable logistic regression were used to identify factors associated with perceived preparedness. Results: Awareness of DCTs was moderate (62.1%), and most participants recognised their potential to improve trial participation (88.5%). However, only 31.0% reported feeling adequately prepared to engage in DCTs. Institutional readiness was limited, with low availability of infrastructure (31.0%) and policies (16.1%). Regulatory familiarity (13.8%) and confidence in ethical guidance (10.3%) were also low. Key barriers included technological limitations (64.4%), data privacy concerns (58.6%), and patient safety issues (56.3%). Preparedness was significantly associated with prior training (p = 0.019) and institutional infrastructure (OR 3.31, 95% CI 1.21–9.09), but not with level of understanding. Conclusion: Stakeholders in Sri Lanka demonstrate strong conceptual support for DCTs but limited operational readiness. Implementation is constrained by system-level gaps rather than attitudinal barriers. Context-specific investment in infrastructure, training, and regulatory frameworks is essential to ensure equitable and sustainable adoption of decentralised clinical trials.

  • Open Access

    No Safe Space: A Systematic Review of Violence Against Women and Girls Across Africa (ANULA-WP1)

    by Nimesha Prashadini, Sohier Elneil, Peter Phiri, Thamudi Sundarapperuma, Janaki Warushahennadi, Vindya Pathiraja, Jian Qingshi, Nirmala Rathnayake, George Eleje, Gayathri Delanerolle

    Introduction Violence against women and girls (VAWG) is a major public health and human rights issue in Africa, with prevalence consistently among the highest globally. According to WHO and UNFPA, one in three women worldwide experience violence in their lifetime, but in sub-Saharan Africa the burden is compounded by poverty, food insecurity, conflict, and weak health systems. Despite its scale, evidence is fragmented across countries and populations, often excluding vulnerable groups such as pregnant women, sex workers, healthcare workers, adolescents, and HIV-positive women. This review synthesises available data to provide a comprehensive understanding of the scope, determinants, outcomes, and interventions addressing VAWG in Africa.Methods We conducted a systematic review in accordance with PRISMA 2020 guidelines. PubMed, Embase, Web of Science, Scopus, African Journals Online, WHO, UNFPA, and Demographic and Health Survey (DHS) repositories were searched (2000–2024). Eligible studies were conducted in African countries and reported prevalence, determinants, outcomes, or interventions for VAWG, including IPV, sexual violence, workplace violence, reproductive coercion, in-law abuse, or community-based violence. Data were extracted independently by two reviewers, appraised for quality, and synthesised using thematic, contextual, trend, and intersectional analyses.Results Eighty studies from 22 African countries were included. Lifetime IPV ranged from 30–65%, pregnancy IPV 25–60%, childhood sexual abuse ~33%, workplace violence 30–62%, and >50% among sex workers. Determinants included alcohol use, poverty, food insecurity, conflict, and inequitable gender norms. Outcomes included maternal morbidity, depression, adverse birth outcomes, HIV/STI risk, and sexual dysfunction. Interventions such as SASA!, Indashyikirwa, CETA, and MAISHA reduced IPV and improved secondary outcomes.ConclusionVAWG in Africa is pervasive, persistent, and particularly concentrated among marginalised groups. Integrated, trauma-informed, and equity-sensitive responses are urgently required to reduce its health and social consequences.

  • Open Access

    Brazil’s National Menstrual Health Programme: Progress, Gaps, and Pathways to Equity; A Concept Note (PLATO WP1)

    by Matheus Brum, Gayathri Delanerolle, Mohammad Haddadi, Lucky Saraswath, Om Kurmi, Peter Phiri, Vindya Pathiraja, Nirmala Rathnayake, George U. Eleje, Bernard Mbwele, et al.

    Brazil recently implemented a national menstrual health program within its Public Health System (Sistema Único de Saúde, SUS), representing a significant policy shift toward recognizing menstrual dignity as a public health and human rights issue. The distribution of menstrual products has expanded rapidly; however, this alone is insufficient to address the structural inequalities affecting menstrual health. This article aims to analyse the implementation of the menstrual health program in Brazil, identify existing inequalities and operational barriers, and propose a research and data framework capable of strengthening monitoring, policymaking, and global collaboration. The study is part of the PLATO project (Work Package 1), integrating public health, gender equality, and implementation science. A narrative analysis was conducted using government and legal documents, demographic and WASH data, and international literature on menstrual equity. Despite strong legislation and intersectoral governance, substantial gaps remain in access, digital inclusion, infrastructure, and participation of marginalized groups. Brazil lacks standardized indicators, interoperable data systems, and monitoring strategies to assess real outcomes. A logic model and equity-centered research architecture are proposed to address these gaps by integrating product provision, WASH, data systems, community participation, and global integration. Brazil has made fundamental progress in menstrual health policy. However, achieving menstrual dignity requires moving beyond product distribution to integrated data collection, infrastructure, equity monitoring, and participatory governance. This framework offers a model applicable to Brazil and other low- and middle-income countries.

  • Open Access

    Borders, Barriers, and Burdens: A Global Comparative Study of Abortion Policies and Access

    by Gayathri Delanerolle, Mohammad Haddadi, Neha Raghuraman, Elizabeth Liles, Nimesha Wijamuni, Nicola Tempest, Vindya Pathiraja, Peter Phiri, George Eleje, Sohier Elneil, et al.

    Background: Abortion is a core component of reproductive healthcare and a critical determinant of maternal health outcomes. Globally, approximately 73 million abortions occur annually, with unsafe abortion contributing to 4.7–13.2% of maternal deaths, primarily in low- and middle-income countries (LMICs). Legal frameworks governing abortion vary widely, ranging from total prohibition to fully integrated care systems. Access is further shaped by health system capacity, procedural barriers, and socio-economic inequities. In an increasingly globalised world, migration adds complexity, as individuals move between countries with differing policies, influencing both direct access to care and regional healthcare dynamics. Understanding these intersecting factors is essential for improving reproductive health equity and reducing preventable morbidity and mortality. Methods: A global comparative analysis was conducted using two integrated datasets covering 100 countries. The first dataset captured legal, operational, and contextual variables, including gestational limits, funding mechanisms, provider cadres, and telemedicine availability. The second dataset provided demographic, socio-economic, and health system indicators. Access Scores were derived from weighted indicators on a 0–10 scale. Analyses included descriptive statistics, bivariate associations, and multivariable ordinal logistic regression. An intersectional approach explored disparities across income groups, geographic regions, and migration pathways, with visualisation tools such as heatmaps, bubble plots, and diaspora exposure differentials. Results: Countries with telemedicine-enabled early medical abortion (tele-EMA) were significantly associated with higher Access Scores (OR ≈1.45), while each additional mandated waiting day reduced odds of liberal access by 7%. Mid-level provider authorisation and public funding alone did not predict improved access. Migration analysis revealed that LMIC-to-HIC flows resulted in marked improvements in abortion access, though benefits were unevenly distributed, leaving vulnerable populations behind. African and Asian LMICs had the lowest Access Scores, reflecting systemic underfunding and restrictive laws. Conclusion: Abortion access is shaped by functional health system design rather than geography alone. Removing procedural barriers, expanding telemedicine, and embedding services within integrated health systems are essential to achieving equitable, sustainable reproductive healthcare worldwide.

  • Open Access

    A Global Synthesis of National and Subnational Abortion Laws and Policies and Their Impact on Women’s Health

    by Mohammad Haddadi, Neha Raghuraman, Gayathri Delanerolle, Elizabeth Liles, Peter Phiri, Sohier Elneil, Vindya Pathiraja, Nimesha Wijamuni, George Eleje, Nicola Tempest, et al.

    Background Human intervention to terminate a pregnancy, while medically effected through a range of pharmaceutical, surgical, and other approaches, is generally referred to in English as “abortion.” It is a fundamental aspect of reproductive healthcare and its availability, regulation, and limits (cultural, familial, legal) are well-documented determinants of women’s and girls’ health worldwide. Despite its routine nature in many health systems, it remains a deeply sensitive issue shaped by cultural, legal, religious, and political factors. Globally, an estimated 73 million abortions occur annually, yet access to safe and timely care is highly variable. In settings where abortion is legal and integrated into healthcare services, it is one of the safest medical procedures. Conversely, restrictive policies force individuals to seek unsafe alternatives, contributing to preventable maternal deaths and long-term health complications. Laws and regulations play a pivotal role in shaping access, but these are influenced by societal norms and often create inequities within and between countries. Methods A systematic review was conducted to identify, collate, and analyse publicly available abortion policies and legislation in English from 1980 to 2025. Data sources included peer-reviewed literature, legal databases, national government portals, and grey literature from global health organisations. Policies were screened, extracted, and appraised using a structured framework. A thematic and contextual analysis was undertaken to explore the legal, operational, and governance components of abortion policies and their implications for access and equity. ResultsPolicies from over 100 countries were included, demonstrating significant global variation. Liberal frameworks, such as those in Iceland, Sweden, England, and New Zealand, were associated with early, safe access through broad on-demand gestational limits and integrated care. Restrictive or grounds-based models, common in parts of Eastern Europe, the Middle East, and Latin America, relied on multi-clinician approvals, waiting periods, and documentation, creating delays and inequities. Federated systems, including the United States and Australia, showed marked regional disparities. Criminal penalties in several countries had a chilling effect, driving cross-border travel and unsafe abortion. Conclusion Global abortion policies vary widely, with many failing to translate legal rights into equitable, practical access. Evidence-informed reforms that integrate health systems research and cultural context are urgently needed to reduce preventable harm and promote reproductive justice.

  • Open Access

    A Systematic Review of Surrogacy in Policy and Practice: Fragmented Commissioning, Global Inequities, and the Case for Evidence-Based Reform (KATHERINE Project)

    by Gayathri Delanrolle, Mohommad Haddadi, Neha Raghuraman, Elizabeth Liles, Nimesha Wijamuni, Nicola Tempest, Vindya Pathiraja, Peter Phiri, George Eleje, Sohier Elneil, et al.

    Introduction: Surrogacy is a rapidly evolving area of reproductive health that spans ethical, legal, clinical, and societal dimensions. Policies governing surrogacy vary widely across countries, shaping access to services, safeguarding measures, and the protection of women and children. While some nations permit regulated altruistic or commercial surrogacy, others impose outright bans, creating global disparities and driving reproductive travel. This review examined publicly available surrogacy policies and guidance, with a focus on commissioning decisions, operational processes, and international cross-border complexities. Methods: Following PRISMA guidelines, a systematic search publicly accessible English-language surrogacy policies and guidance documents were identified through a comprehensive search of health service commissioning bodies, government agencies, and professional organisations. Thematic analysis was conducted to explore policy scope, legal frameworks, safeguarding procedures, and international variation. Policies were then compared to assess areas of convergence and divergence across global settings. Results: Globally, surrogacy regulation is highly fragmented. In Europe, most countries prohibit commercial surrogacy and, in some cases, altruistic arrangements, while nations such as the UK, Ireland, and Greece allow tightly controlled altruistic surrogacy. North America shows a patchwork approach, with some US states and Canada permitting altruistic or compensated arrangements under varying levels of regulation. In Asia, historical hubs such as India and Thailand have shifted from permissive commercial surrogacy to restrictive altruistic-only models following concerns over exploitation. Africa remains largely unregulated, except for South Africa’s comprehensive legal framework. Across settings, recurrent themes included safeguarding concerns, ethical debates over exploitation versus autonomy, and challenges in determining legal parentage and nationality. Cross-border arrangements amplify these complexities, often leaving children stateless or without clear legal protections. Conclusion: The absence of harmonised frameworks perpetuates inequities in women’s health and cross-border surrogacy, often exposing individuals to financial, legal, and health risks. These challenges underscore the urgent need for evidence-based policies and fairer, more equitable approaches to surrogacy.